Is Aurora Cannabis (TSX:ACB) Really Turning Around?

Top pot stock Aurora Cannabis (TSX:ACB)(NYSE:ACB) surged 67% on strong quarterly earnings. But is it really turning around?

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

The Canadian cannabis giant Aurora Cannabis (TSX:ACB)(NYSE:ACB) reported its third-quarter earnings last week. Better-than-expected numbers sent the stock through the roof, surging almost 67% on Friday. There was a significant surge in its volume as well. Nearly 18 million shares exchanged hands against its three-month average daily volume of 1.1 million.

But is it really out of the woods? Let’s dig a little deeper.

Aurora Cannabis: Quarterly earnings sent the stock through the roof

Aurora’s quarterly numbers improved on several fronts compared to the quarter earlier. Michael Singer, Aurora’s interim CEO and chairman, said, “We are turning this ship around, and it’s a big ship,” BNN Bloomberg reported.

Aurora’s quarterly numbers were encouraging on some fronts. It reported quarterly net revenues of $76 million — an increase of 33% compared to the quarter earlier. Higher demand during the lockdowns played out well for Aurora Cannabis. Its top-line growth indeed came as a relief for investors compared to a dull second quarter. However, its revenues had more than doubled year over year in the fiscal year 2018 and 2019.

Notably, Aurora’s losses widened in the recently reported quarter. Its loss came in at $1.37 per share against a loss of $1.08 per share in the second quarter. Importantly, losses widening despite a revenue increase could bother discerned investors.

The management expects it to turn EBITDA positive in fiscal Q1 2021, which is during the July-September quarter of 2020.

Aurora’s cash burn improves

Aurora’s cash burn was another highlight in its latest quarterly release. It burned $154 million in cash in the reported quarter, almost 43% less compared to the previous quarter. This indicates that the company is on track to its transformation plan announced in February. This lower cash burn could help it become EBITDA positive in the next quarter, as management expects.

It ended the quarter with $230 million in cash. Once struggling for cash, Aurora Cannabis now looks well capitalized, and this cash could keep it going for the next several quarters.

An increasing number of retail stores, along with advanced recreational product range, should help Aurora Cannabis’s sales. Top-line expansion and consistent efforts on trimming operating expenses might turn the company profitable.

What should investors do?

Many potential investors would have overlooked Aurora Cannabis, given its recent reverse stock split. Although Aurora stock has soared approximately 80% in the last two trading days, it is still down more than 50% so far this year. That’s largely been the trend for pot stocks recently. Slower demand growth, saturated markets, and regulatory concerns have mainly hampered cannabis stocks in the last few years. The Horizons Marijuana Life Sciences Index ETF has lost almost 70% in the last 12 months.

Investors can expect excessive volatility to continue in the Aurora Cannabis stock. While the stock looks well placed compared to a few weeks ago, it looks significantly overvalued at the moment. Investors can wait for a pullback to enter. Importantly, although Aurora Cannabis looks to be turning around, I believe its widened losses, despite a revenue increase, could concern investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vineet Kulkarni has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »